dacarbazine has been researched along with Cancer of Paranasal Sinus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broes, K; Claes, J; Cox, T; Deben, K; Joosens, E; Maes, A; Mebis, J; Schepers, S; Theunissen, K; Van Ginderachter, L | 1 |
| Deitmer, T; Eising, E; Naszaly, A; Pötter, R | 1 |
2 other study(ies) available for dacarbazine and Cancer of Paranasal Sinus
| Article | Year |
|---|---|
Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Ethmoid Sinus; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paranasal Sinus Neoplasms; Temozolomide | 2015 |
[Role of radiotherapy in esthesioneuroblastoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cranial Nerve Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Olfactory Nerve; Paranasal Sinus Neoplasms; Radiotherapy, High-Energy; Vincristine | 1988 |